6 European Projects Found
Searched on 125080 European Projects
FINISHED
Best EScalation Treatment in Multiple Sclerosis (MS) (BEST MS)
Start date: Nov 1, 2012, End date: Oct 31, 2016,
"Multiple Sclerosis (MS) is a devastating disease of the central nervous system affecting 2.5 million worldwide. MS is a field of constant therapeutic innovation, a fact which brings hope to young adults since MS is one of the most frequent causes of severe handicap. A major unmet need is to rationalize treatment decisions. To date, there is no way of predicting which patients will best respond to ...
Read Project
5
Partners Participants
FINISHED
Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria (SysMalVac)
Start date: Jan 1, 2013, End date: Dec 31, 2014,
Vaccine development is an empirical process (trial and error) and involves a long, expensive clinical development pipeline to license an efficacious vaccine candidate. Better tools for vaccine evaluation are needed to adapt to a rising number of candidate vaccines entering clinical trials for many diseases. Surrogate biomarkers of immunity offer the possibility of expediting the clinical developme ...
Read Project
8
Partners Participants
FINISHED
A new generation of fibre-based diagnostic sensors (BiognostiX)
Start date: Apr 1, 2011, End date: Mar 31, 2014,
The BiognostiX project will develop technologies and flexible manufacturing methods for the fabrication of inexpensive biodiagnostic sensors on fibre-based substrates (e.g. paper or card).Fabrication will be based on fluid-jet techniques, allowing the sensor platforms to be reconfigurable (customisable) at the point of manufacture to perform different biodiagnostic test functions including quantit ...
Read Project
6
Partners Participants
FINISHED
Collaborative European effort to Develop Diabetes Diagnostics (CEED3)
Start date: Dec 1, 2008, End date: Nov 30, 2012,
"CEED3 (Collaborative European Effort to Develop Diabetes Diagnostics) has as its central objective, the development of diagnostic tools to differentiate specific subgroups of diabetic patients to allow individualisation of patient care. CEED3 will achieve this by integrating basic science findings from animal models, cell studies, and large scale genetic studies with clinical observations and tes ...
Read Project
12
Partners Participants
FINISHED
United Europeans for the Development of Pharmacogenomics in Multiple Sclerosis (UEPHA-MS)
Start date: Sep 15, 2008, End date: Sep 14, 2012,
"Multiple sclerosis (MS) is a chronic inflammatory, disabling disease of the central nervous system. Recent studies suggest that over the last 50 years a disproportional increase in incidence of MS in women has taken place. The lifetime costs of MS exceed 1.5 million € per case in the UK, and are likely to be similar in other European countries. There is no definitive cure for MS. Immunomodulatory ...
Read Project
12
Partners Participants
FINISHED
Mucosal protease and their inhibitors in inflammatory bowel disease: From etiopathogenetic insight to innovative therapy (IBDase)
Start date: Mar 1, 2008, End date: May 31, 2011,
IBDase addresses the etiology and pathogenesis of inflammatory bowel disease (IBD) with a multidisciplinary plan for innovative diagnosis and therapy focused on mucosal proteases and their inhibitors (P/PIs). The incidence of IBD, a multifactorial disease influenced by environmental factors in a background of complex genetic susceptibility, is rising, particularly among European children. Current ...
Read Project
